News and press releases
A Game-Changer in Myopia Management is Now Available in Malaysia
We are excited to announce that our new partner in Malaysia, Transmedic Ophthalmology, will be launching and showcasing the Eyerising Myopia Management Device at the World Congress of Paediatric Ophthalmology and Strabismus (WCPOS) in Kuala[...]
Study Finds Red Light Therapy Cuts Ocular Elongation Rate and SER Increase
Article outlines the amazing results of RLRL in high myopia patients. “Repeated low-level red light demonstrates much stronger treatment efficacy among high myopia in children and adolescents aged six to 16 years, with 53.3% experiencing[...]
Mark your calendars for July 12!
Join us at the World Congress of Paediatric Ophthalmology and Strabismus, breakfast symposium for an insightful panel discussion on Repeated Low-Level Red-Light Therapy for Myopia, featuring a panel of world-class experts. Don't miss this opportunity[...]
3rd Ho Chi Minh City Ophthalmology Conference 2024
With an aim to provide a solution to the increasing number of children with myopia, we are proud to introduce Repeated Low-Level Red-Light Therapy (RLRL) in Vietnam. We will be attending the 3rd Ho Chi[...]
The UK Perspective on Eyerising’s RLRL Myopia Management Device
The buzz around repeated low-level red light therapy (RLRL) is growing, stemming from multiple studies coming out of China. But is it just as effective in the UK? At recent global optometry conference, Dr. Neema[...]
Repeated Low-Level Red Light Therapy for Myopia Control in High Myopia Children and Adolescents: A Randomized Clinical Trial
Exciting news! A new Randomized Clinical Trial on Repeated Low-Level Red-Light Therapy (RLRL) for Myopia Control in High Myopia Children has just been published. This comes just in time for the upcoming RLRL Webinar with[...]
